Manufacturer profileSHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
IndonesiaChina20 products registered
VerifiedKemenkes (Ministry of Health) · official registry
20
Total Products
20
Product Names
2
Product Classes
3
Risk Classes
Regulatory footprint
Search SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. across other regulatory registries
Thailand
European Union
Colombia
South Korea
Canada
EcuadorRisk classification breakdown
Distribution of products across risk classes
Kelas Resiko : A15.0% of total
Kelas Resiko : B1890.0% of total
Kelas Resiko : C15.0% of total
Product class portfolio
Products organized by product class
Kelas : 2
Laboratory Automation System SATLARS™ T8, MAGLUMI Osteocalcin (CLIA), MAGLUMI EPO (CLIA), MAGLUMI ICA (CLIA), MAGLUMI Anti-Cardiolipin IgM (CLIA) ... and 14 more products in this class
19 Products
Kelas : 1
MAGLUMI Sample Release Agent
1 Products
Recent registrations (20 most recent)
Most recently registered products with Ministry of Health
Laboratory Automation System SATLARS™ T8
Feb 12, 2025
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
MAGLUMI Osteocalcin (CLIA)
Feb 3, 2025
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
MAGLUMI EPO (CLIA)
Feb 3, 2025
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
MAGLUMI ICA (CLIA)
Jan 15, 2025
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
MAGLUMI Anti-Cardiolipin IgM (CLIA)
Jan 9, 2025
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
MAGLUMI Anti-Cardiolipin IgG (CLIA)
Jan 9, 2025
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
MAGLUMI Anti-Cardiolipin (CLIA)
Jan 9, 2025
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
MAGLUMI Anti-β2-Glycoprotein 1 IgM (CLIA)
Jan 7, 2025
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
MAGLUMI Anti-Cardiolipin IgA (CLIA)
Jan 7, 2025
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
MAGLUMI Anti-β2-Glycoprotein 1 IgG (CLIA)
Jan 7, 2025
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
MAGLUMI AMH (CLIA)
Jan 4, 2025
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
MAGLUMI Anti-SS-A/Ro IgG (CLIA)
Jan 3, 2025
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
MAGLUMI Anti-SS-B IgG (CLIA)
Jan 3, 2025
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
MAGLUMI Anti-IA2 (CLIA)
Jan 3, 2025
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
MAGLUMI TRAb (CLIA)
Dec 27, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
MAGLUMI Free-Testosterone (CLIA)
Dec 23, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
MAGLUMI T-Uptake (CLIA)
Dec 23, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
MAGLUMI Sample Release Agent
Dec 23, 2024
- Class
- Kelas : 1
- Risk Class
- Kelas Resiko : A
MAGLUMI Thyroglobulin (CLIA)
Dec 19, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
MAGLUMI Free PSA (CLIA)
Dec 19, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
About this profile
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. from China is a medical device manufacturer with 20 registered products in the Indonesia Ministry of Health database through Pure Global AI's free platform. The company produces 20 unique product types across 2 product classes.
This page provides comprehensive manufacturer intelligence including complete product portfolio, risk class distribution, and product class analysis. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify manufacturers, analyze portfolios, and discover partnership opportunities efficiently.